Gilles Buchwalter
- Molecular Biology top 10%
- Oncology top 5%
- Cancer Research top 5%
- Pulmonary and Respiratory Medicine top 10%
- Genetics top 10%
- Co-authors
- Bohdan WasylykChristian GroßMyles BrownRinath JeselsohnRachel SchiffCarmine De AngelisHong ZhengKari Alitalo
- Topics
- Advanced Breast Cancer Therapies (4 papers)Estrogen and related hormone effects (3 papers)Cancer-related Molecular Pathways (3 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryThe EMBO Journal
- Partner nations
- United StatesFranceGermany
In The Last Decade
Gilles Buchwalter
15 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 82
- Molecular Biology 730
- Oncology 483
- Cancer Research 347
- Pulmonary and Respiratory Medicine 305
- Genetics 227
Countries citing papers authored by Gilles Buchwalter
This map shows the geographic impact of Gilles Buchwalter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gilles Buchwalter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gilles Buchwalter more than expected).
Fields of papers citing papers by Gilles Buchwalter
This network shows the impact of papers produced by Gilles Buchwalter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gilles Buchwalter. The network helps show where Gilles Buchwalter may publish in the future.
Co-authorship network of co-authors of Gilles Buchwalter
This figure shows the co-authorship network connecting the top 25 collaborators of Gilles Buchwalter. A scholar is included among the top collaborators of Gilles Buchwalter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gilles Buchwalter. Gilles Buchwalter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 32 | |
| 2 | 1 | |
| 3 | ESR1 mutations—a mechanism for acquired endocrine resistance in breast cancerbreakdown → | 454 |
| 4 | 46 | |
| 5 | 49 | |
| 6 | 11 | |
| 7 | 1 | |
| 8 | 51 | |
| 9 | 20 | |
| 10 | 42 | |
| 11 | 29 | |
| 12 | 15 | |
| 13 | 74 | |
| 14 | 299 | |
| 15 | 105 |
About Gilles Buchwalter
Gilles Buchwalter is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 15 papers that have together received 1.2k indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (4 papers), Estrogen and related hormone effects (3 papers) and Cancer-related Molecular Pathways (3 papers). The work is most often cited by research in Cancer Research (347 citations), Oncology (483 citations) and Molecular Biology (730 citations). Gilles Buchwalter has collaborated with scholars based in United States, France and Germany. Frequent co-authors include Bohdan Wasylyk, Christian Groß, Myles Brown, Rinath Jeselsohn, Rachel Schiff, Carmine De Angelis, Hong Zheng, Kari Alitalo, Philippe Moerman and A. Ayadi. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The EMBO Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.